Results
|
|
9661.
|
|
|
|
9662.
|
|
|
|
9663.
|
|
|
|
9664.
|
|
|
|
9665.
|
Granulocyte-macrophage colony-stimulating factor increases dose intensity of chemotherapy in small cell lung cancer. Relationship between clinical results, peripheral blood cell modifications, and bone marrow kinetics. [electronic resource] by
- Paccagnella, A
- Favaretto, A
- Riccardi, A
- Danova, M
- Ghiotto, C
- Giordano, M
- Pappagallo, G
- Comis, S
- Panozzo, M
- Chieco-Bianchi, L
Producer: 19930824
In:
Cancer vol. 72
Availability: No items available.
|
|
|
9666.
|
Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors. [electronic resource] by
- Budman, D R
- Igwemezie, L N
- Kaul, S
- Behr, J
- Lichtman, S
- Schulman, P
- Vinciguerra, V
- Allen, S L
- Kolitz, J
- Hock, K
Producer: 19941010
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 12
Availability: No items available.
|
|
|
9667.
|
|
|
|
9668.
|
|
|
|
9669.
|
|
|
|
9670.
|
Use of high-dose chemotherapy plus granulocyte colony-stimulating factor for the salvage of refractory or resistant-relapse lymphoma patients without stem cell support. [electronic resource] by
- Koç, H
- Arslan, O
- Gürman, G
- Akan, H
- Ozcan, M
- Ilhan, O
- Aydoğdu, I
- Arat, M
- Beksaç, M
- Konuk, N
- Uysal, A
Producer: 19971205
In:
Acta haematologica vol. 98
Availability: No items available.
|
|
|
9671.
|
Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis. [electronic resource] by
- Strauss, G M
- Lynch, T J
- Elias, A D
- Jacobs, C
- Herbst, R
- Leong, T
- Lynch, C
- Kwiatkowski, D J
- Carey, R W
- Grossbard, M L
- Skarin, A T
Producer: 19971021
In:
Seminars in oncology vol. 24
Availability: No items available.
|
|
|
9672.
|
|
|
|
9673.
|
|
|
|
9674.
|
|
|
|
9675.
|
|
|
|
9676.
|
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. [electronic resource] by
- Trillet-Lenoir, V
- Green, J
- Manegold, C
- Von Pawel, J
- Gatzemeier, U
- Lebeau, B
- Depierre, A
- Johnson, P
- Decoster, G
- Tomita, D
Producer: 19931101
In:
European journal of cancer (Oxford, England : 1990) vol. 29A
Availability: No items available.
|
|
|
9677.
|
Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML). [electronic resource] by
- Ganser, A
- Heil, G
- Seipelt, G
- Hofmann, W
- Fischer, J T
- Langer, W
- Brockhaus, W
- Kolbe, K
- Ittel, T H
- Brack, N
- Fuhr, H G
- Knuth, P
- Höffken, K
- Bergmann, L
- Hoelzer, D
Producer: 20000229
In:
Annals of hematology vol. 79
Availability: No items available.
|
|
|
9678.
|
|
|
|
9679.
|
|
|
|
9680.
|
Dexa-BEAM: an effective regimen for cytoreduction prior to high-dose chemotherapy with autologous stem cell support for patients with relapsed/refractory mantle-cell lymphoma. [electronic resource] by
- Josting, A
- Reiser, M
- Wickramanayake, P D
- Rueffer, U
- Draube, A
- Söhngen, D
- Tesch, H
- Wolf, J
- Diehl, V
- Engert, A
Producer: 20000518
In:
Leukemia & lymphoma vol. 37
Availability: No items available.
|